LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 54

Search options

  1. Article ; Online: State of the art on microbubble cavitation monitoring and feedback control for blood-brain-barrier opening using focused ultrasound.

    Mondou, Paul / Mériaux, Sébastien / Nageotte, Florent / Vappou, Jonathan / Novell, Anthony / Larrat, Benoit

    Physics in medicine and biology

    2023  Volume 68, Issue 18

    Abstract: Focused ultrasound (FUS) is a non-invasive and highly promising method for targeted and reversible blood-brain barrier permeabilization. Numerous preclinical studies aim to optimize the localized delivery of drugs using this method in rodents and non- ... ...

    Abstract Focused ultrasound (FUS) is a non-invasive and highly promising method for targeted and reversible blood-brain barrier permeabilization. Numerous preclinical studies aim to optimize the localized delivery of drugs using this method in rodents and non-human primates. Several clinical trials have been initiated to treat various brain diseases in humans using simultaneous BBB permeabilization and drug injection. This review presents the state of the art of
    MeSH term(s) Animals ; Humans ; Blood-Brain Barrier ; Feedback ; Microbubbles ; Ultrasonics/methods ; Brain Diseases ; Drug Delivery Systems/methods
    Language English
    Publishing date 2023-09-08
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 208857-5
    ISSN 1361-6560 ; 0031-9155
    ISSN (online) 1361-6560
    ISSN 0031-9155
    DOI 10.1088/1361-6560/ace23e
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Transcranial ultrasound simulations: A review.

    Angla, Célestine / Larrat, Benoit / Gennisson, Jean-Luc / Chatillon, Sylvain

    Medical physics

    2022  Volume 50, Issue 2, Page(s) 1051–1072

    Abstract: Transcranial ultrasound is more and more used for therapy and imaging of the brain. However, the skull is a highly attenuating and aberrating medium, with different structures and acoustic properties among samples and even within a sample. Thus, case- ... ...

    Abstract Transcranial ultrasound is more and more used for therapy and imaging of the brain. However, the skull is a highly attenuating and aberrating medium, with different structures and acoustic properties among samples and even within a sample. Thus, case-specific simulations are needed to perform transcranial focused ultrasound interventions safely. In this article, we provide a review of the different methods used to model the skull and to simulate ultrasound propagation through it.
    MeSH term(s) Computer Simulation ; Ultrasonography/methods ; Brain/diagnostic imaging ; Skull/diagnostic imaging ; Acoustics
    Language English
    Publishing date 2022-09-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 188780-4
    ISSN 2473-4209 ; 0094-2405
    ISSN (online) 2473-4209
    ISSN 0094-2405
    DOI 10.1002/mp.15955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [

    Soyer, Amélie / Goutal, Sébastien / Leterrier, Sarah / Marie, Solène / Larrat, Benoit / Selingue, Erwan / Winkeler, Alexandra / Sarazin, Marie / Bottlaender, Michel / Tournier, Nicolas

    Annales pharmaceutiques francaises

    2024  

    Abstract: Numerous studies suggest that blood-brain barrier (BBB) dysfunction may contribute to the progression of Alzheimer's disease (AD). Clinically available neuroimaging methods are needed for quantitative "scoring" of BBB permeability in AD patients. [ ...

    Abstract Numerous studies suggest that blood-brain barrier (BBB) dysfunction may contribute to the progression of Alzheimer's disease (AD). Clinically available neuroimaging methods are needed for quantitative "scoring" of BBB permeability in AD patients. [
    Language English
    Publishing date 2024-04-22
    Publishing country France
    Document type Journal Article
    ZDB-ID 307-4
    ISSN 0003-4509
    ISSN 0003-4509
    DOI 10.1016/j.pharma.2024.04.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Anticancer drug delivery by focused ultrasound-mediated blood-brain/tumor barrier disruption for glioma therapy: From benchside to bedside.

    Bérard, Charlotte / Truillet, Charles / Larrat, Benoit / Dhermain, Frédéric / Estève, Marie-Anne / Correard, Florian / Novell, Anthony

    Pharmacology & therapeutics

    2023  Volume 250, Page(s) 108518

    Abstract: The therapeutic management of gliomas remains particularly challenging. Brain tumors present multiple obstacles that make therapeutic innovation complex, mainly due to the presence of blood-tumor and blood-brain barriers (BTB and BBB, respectively) which ...

    Abstract The therapeutic management of gliomas remains particularly challenging. Brain tumors present multiple obstacles that make therapeutic innovation complex, mainly due to the presence of blood-tumor and blood-brain barriers (BTB and BBB, respectively) which prevent penetration of anticancer agents into the brain parenchyma. Focused ultrasound-mediated BBB disruption (FUS-BBBD) provides a physical method for non-invasive, local, and reversible BBB disruption. The safety of this technique has been demonstrated in small and large animal models. This approach promises to enhance drug delivery into the brain tumor and therefore to improve survival outcomes by repurposing existing drugs. Several clinical trials continue to be initiated in the last decade. In this review, we provide an overview of the rationale behind the use of FUS-BBBD in gliomas and summarize the preclinical studies investigating different approaches (free drugs, drug-loaded microbubbles and drug-loaded nanocarriers) in combination with this technology in in vivo glioma models. Furthermore, we discuss the current state of clinical trials and devices developed and review the challenges to overcome for clinical use of FUS-BBBD in glioma therapy.
    Language English
    Publishing date 2023-08-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 194735-7
    ISSN 1879-016X ; 0163-7258
    ISSN (online) 1879-016X
    ISSN 0163-7258
    DOI 10.1016/j.pharmthera.2023.108518
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function

    Goutal, Sébastien / Novell, Anthony / Leterrier, Sarah / Breuil, Louise / Selingue, Erwan / Gerstenmayer, Matthieu / Marie, Solène / Saubaméa, Bruno / Caillé, Fabien / Langer, Oliver / Truillet, Charles / Larrat, Benoît / Tournier, Nicolas

    Journal of Controlled Release.

    2023  

    Abstract: The P-glycoprotein (P-gp/ABCB1) is a major efflux transporter which impedes the brain delivery of many drugs across the blood-brain barrier (BBB). Focused ultrasound with microbubbles (FUS) enables BBB disruption, which immediate and delayed impact on P- ... ...

    Abstract The P-glycoprotein (P-gp/ABCB1) is a major efflux transporter which impedes the brain delivery of many drugs across the blood-brain barrier (BBB). Focused ultrasound with microbubbles (FUS) enables BBB disruption, which immediate and delayed impact on P-gp function remains unclear. Positron emission tomography (PET) imaging using the radiolabeled substrate [¹¹C]metoclopramide provides a sensitive and translational method to study P-gp function at the living BBB. A FUS protocol was devised in rats to induce a substantial and targeted disruption of the BBB in the left hemisphere. BBB disruption was confirmed by the Evan's Blue extravasation test or the minimally-invasive contrast-enhanced MRI. The expression of P-gp was measured 24 h or 48 h after FUS using immunostaining and fluorescence microscopy. The brain kinetics of [¹¹C]metoclopramide was studied by PET at baseline, and both immediately or 24 h after FUS, with or without half-maximum P-gp inhibition (tariquidar 1 mg/kg). In each condition (n = 4-5 rats per group), brain exposure of [¹¹C]metoclopramide was estimated as the area-under-the-curve (AUC) in regions corresponding to the sonicated volume in the left hemisphere, and the contralateral volume. Kinetic modeling was performed to estimate the uptake clearance ratio (R₁) of [¹¹C]metoclopramide in the sonicated volume relative to the contralateral volume. In the absence of FUS, half-maximum P-gp inhibition increased brain exposure (+135.0 ± 12.9%, p < 0.05) but did not impact R₁ (p > 0.05). Immediately after FUS, BBB integrity was selectively disrupted in the left hemisphere without any detectable impact on the brain kinetics of [¹¹C]metoclopramide compared with the baseline group (p > 0.05) or the contralateral volume (p > 0.05). 24 h after FUS, BBB integrity was fully restored while P-gp expression was maximally down-regulated (−45.0 ± 4.5%, p < 0.001) in the sonicated volume. This neither impacted AUC nor R₁ in the FUS + 24 h group (p > 0.05). Only when P-gp was inhibited with tariquidar were the brain exposure (+130 ± 70%) and R₁(+29.1 ± 15.4%) significantly increased in the FUS + 24 h/tariquidar group, relative to the baseline group (p < 0.001). We conclude that the brain kinetics of [¹¹C]metoclopramide specifically depends on P-gp function rather than BBB integrity. Delayed FUS-induced down-regulation of P-gp function can be detected. Our results suggest that almost complete down-regulation is required to substantially enhance the brain delivery of P-gp substrates.
    Keywords P-glycoproteins ; blood-brain barrier ; brain ; fluorescence microscopy ; metoclopramide ; microbubbles ; positron-emission tomography ; radiolabeling ; ultrasonics ; Blood-brain barrier integrity ; Brain delivery ; Efflux transporter ; Membrane transporters ; Therapeutic ultrasound
    Language English
    Publishing place Elsevier B.V.
    Document type Article ; Online
    Note Pre-press version
    ZDB-ID 632533-6
    ISSN 1873-4995 ; 0168-3659
    ISSN (online) 1873-4995
    ISSN 0168-3659
    DOI 10.1016/j.jconrel.2023.08.012
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: About the Marty model of blood-brain barrier closure after its disruption using focused ultrasound.

    Conti, Allegra / Mériaux, Sébastien / Larrat, Benoit

    Physics in medicine and biology

    2019  Volume 64, Issue 14, Page(s) 14NT02

    Abstract: Many studies have demonstrated that pulsed ultrasound combined with circulating microbubbles can permeate the blood-brain barrier in a reversible manner. In 2012, our group demonstrated that the BBB remains permeable to small MRI contrast agents up to 24  ...

    Abstract Many studies have demonstrated that pulsed ultrasound combined with circulating microbubbles can permeate the blood-brain barrier in a reversible manner. In 2012, our group demonstrated that the BBB remains permeable to small MRI contrast agents up to 24 h after ultrasound application and also that this duration was dependent on nanoparticle size. We derived a simple theoretical model explaining these observations (Marty et al 2012 J. Cereb. Blood Flow Metab. 32 1948-58). However, in this original paper the expression of the BBB closure time (t
    MeSH term(s) Blood-Brain Barrier/drug effects ; Blood-Brain Barrier/metabolism ; Blood-Brain Barrier/radiation effects ; Brain/drug effects ; Brain/metabolism ; Brain/radiation effects ; Contrast Media/metabolism ; Drug Delivery Systems/methods ; Humans ; Magnetic Resonance Imaging/methods ; Microbubbles ; Models, Statistical ; Sonication/methods ; Ultrasonic Waves
    Chemical Substances Contrast Media
    Language English
    Publishing date 2019-07-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 208857-5
    ISSN 1361-6560 ; 0031-9155
    ISSN (online) 1361-6560
    ISSN 0031-9155
    DOI 10.1088/1361-6560/ab259d
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Amphiphilic and Perfluorinated Poly(3-Hydroxyalkanoate) Nanocapsules for

    Le Gal, Marion / Renard, Estelle / Simon-Colin, Christelle / Larrat, Benoit / Langlois, Valérie

    Bioengineering (Basel, Switzerland)

    2021  Volume 8, Issue 9

    Abstract: Nanoparticles have recently emerged as valuable tools in biomedical imaging techniques. Here PEGylated and fluorinated nanocapsules based on poly(3-hydroxyalkanoate) containing a liquid core of perfluorooctyl bromide PFOB were formulated by an emulsion- ... ...

    Abstract Nanoparticles have recently emerged as valuable tools in biomedical imaging techniques. Here PEGylated and fluorinated nanocapsules based on poly(3-hydroxyalkanoate) containing a liquid core of perfluorooctyl bromide PFOB were formulated by an emulsion-evaporation process as potential
    Language English
    Publishing date 2021-09-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2746191-9
    ISSN 2306-5354
    ISSN 2306-5354
    DOI 10.3390/bioengineering8090121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Molecular Imaging of Ultrasound-Mediated Blood-Brain Barrier Disruption in a Mouse Orthotopic Glioblastoma Model.

    Bastiancich, Chiara / Fernandez, Samantha / Correard, Florian / Novell, Anthony / Larrat, Benoit / Guillet, Benjamin / Estève, Marie-Anne

    Pharmaceutics

    2022  Volume 14, Issue 10

    Abstract: Glioblastoma (GBM) is an aggressive and malignant primary brain tumor. The blood-brain barrier (BBB) limits the therapeutic options available to tackle this incurable tumor. Transient disruption of the BBB by focused ultrasound (FUS) is a promising and ... ...

    Abstract Glioblastoma (GBM) is an aggressive and malignant primary brain tumor. The blood-brain barrier (BBB) limits the therapeutic options available to tackle this incurable tumor. Transient disruption of the BBB by focused ultrasound (FUS) is a promising and safe approach to increase the brain and tumor concentration of drugs administered systemically. Non-invasive, sensitive, and reliable imaging approaches are required to better understand the impact of FUS on the BBB and brain microenvironment. In this study, nuclear imaging (SPECT/CT and PET/CT) was used to quantify neuroinflammation 48 h post-FUS and estimate the influence of FUS on BBB opening and tumor growth in vivo. BBB disruptions were performed on healthy and GBM-bearing mice (U-87 MG xenograft orthotopic model). The BBB recovery kinetics were followed and quantified by [99mTc]Tc-DTPA SPECT/CT imaging at 0.5 h, 3 h and 24 h post-FUS. The absence of neuroinflammation was confirmed by [18F]FDG PET/CT imaging 48 h post-FUS. The presence of the tumor and its growth were evaluated by [68Ga]Ga-RGD
    Language English
    Publishing date 2022-10-19
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics14102227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.

    Conti, Allegra / Geffroy, Francoise / Kamimura, Hermes A S / Novell, Anthony / Tournier, Nicolas / Mériaux, Sébastien / Larrat, Benoit

    International journal of molecular sciences

    2022  Volume 23, Issue 24

    Abstract: The blood-brain barrier (BBB) controls brain homeostasis; it is formed by vascular endothelial cells that are physically connected by tight junctions (TJs). The BBB expresses efflux transporters such as P-glycoprotein (P-gp) and breast cancer resistance ... ...

    Abstract The blood-brain barrier (BBB) controls brain homeostasis; it is formed by vascular endothelial cells that are physically connected by tight junctions (TJs). The BBB expresses efflux transporters such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), which limit the passage of substrate molecules from blood circulation to the brain. Focused ultrasound (FUS) with microbubbles can create a local and reversible detachment of the TJs. However, very little is known about the effect of FUS on the expression of efflux transporters. We investigated the in vivo effects of moderate acoustic pressures on both P-gp and BCRP expression for up to two weeks after sonication. Magnetic resonance-guided FUS was applied in the striatum of 12 rats. P-gp and BCRP expression were determined by immunohistochemistry at 1, 3, 7, and 14 days postFUS. Our results indicate that FUS-induced BBB opening is capable of (i) decreasing P-gp expression up to 3 days after sonication in both the treated and in the contralateral brain regions and is capable of (ii) overexpressing BCRP up to 7 days after FUS in the sonicated regions only. Our findings may help improve FUS-aided drug delivery strategies by considering both the mechanical effect on the TJs and the regulation of P-gp and BCRP.
    Language English
    Publishing date 2022-12-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms232415488
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Planning Framework for Robot-assisted Blood-Brain Barrier Opening with Focused Ultrasound.

    Thomas, Gaelle / Barbe, Laurent / Larrat, Benoit / Agou, Pauline / Vappou, Jonathan / Nageotte, Florent

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

    2020  Volume 2020, Page(s) 5033–5036

    Abstract: This article presents a method to plan BloodBrain Barrier (BBB) disruption with Focused Ultrasound, under neuronavigated robotic assistance. Robotic and acoustic constraints are defined to estimate brain target accessibility. The relevance of the ... ...

    Abstract This article presents a method to plan BloodBrain Barrier (BBB) disruption with Focused Ultrasound, under neuronavigated robotic assistance. Robotic and acoustic constraints are defined to estimate brain target accessibility. The relevance of the proposed framework is illustrated in specific brain target examples.
    MeSH term(s) Biological Transport ; Blood-Brain Barrier/diagnostic imaging ; Brain/diagnostic imaging ; Robotics ; Ultrasonography
    Language English
    Publishing date 2020-10-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2694-0604
    ISSN (online) 2694-0604
    DOI 10.1109/EMBC44109.2020.9175849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top